RenaissanceRe (RNR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Achieved net income of $1.8B, operating income of $2.2B, and 19.3% ROE in 2024, with 26% growth in tangible book value per share plus dividends.
Completed Validus acquisition, driving 32.4% growth in gross premiums written to $11.7B and strengthening underwriting, fee, and investment income.
Enhanced capital management, increasing share repurchase authorization to $750M and repurchasing over $900M in shares through early 2025.
Maintained a strong, collaborative culture with a focus on talent development, succession planning, and pay-for-performance.
Voting matters and shareholder proposals
Shareholders to vote on election of one Class II and four Class III directors, advisory say-on-pay, and appointment of PricewaterhouseCoopers Ltd. as auditor.
Board recommends voting FOR all proposals.
Majority vote standard for uncontested director elections; classified board structure maintained for continuity.
Board of directors and corporate governance
Board is 91% independent, with 45% diversity and an average tenure of 9 years.
Three new directors added in the last three years, including Loretta J. Mester in 2024.
Board committees include Audit, Governance and Human Capital, and Investment and Risk Management, with a streamlined Standing Committee for strategic transactions.
Annual board and committee self-evaluations, third-party assessments, and robust director orientation and education.
Strong shareholder engagement program, with 68% of shares represented in recent outreach.
Latest events from RenaissanceRe
- Key votes include director elections, executive pay, incentive plan, and auditor appointment.RNR
Proxy Filing18 Mar 2026 - 2025 saw record returns, board refreshment, and enhanced ESG focus, with all proposals recommended for approval.RNR
Proxy Filing18 Mar 2026 - Net income hit $2.65B in 2025, with 30.8% book value growth despite major loss events.RNR
Q4 20254 Feb 2026 - Q2 2024 saw $495M net income, 29% premium growth, and strong returns from Validus.RNR
Q2 20242 Feb 2026 - Q3 net income soared to $1.17B, with strong premium growth and investment gains.RNR
Q3 202415 Jan 2026 - Record $2.2B operating income and 26% tangible book value growth despite catastrophe losses.RNR
Q4 20249 Jan 2026 - Catastrophe losses led to an operating loss, but investment gains and capital strength persisted.RNR
Q1 202520 Dec 2025 - Key votes include director elections, executive pay, and auditor approval for 2025.RNR
Proxy Filing2 Dec 2025 - Q2 2025 net income rose 67% with a 75.1% combined ratio and strong book value growth.RNR
Q2 20255 Nov 2025